analyzed the hematological parameters of patients with COVID-19 and found that they had higher levels of inflammatory markers, such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), as well as lower levels of hemoglobin and red blood cells compared to healthy controls. The gene discussed is CRP; the disease is COVID-19.